Stay updated on Pembrolizumab Plus Paclitaxel in HER2- Breast Cancer Clinical Trial

Sign up to get notified when there's something new on the Pembrolizumab Plus Paclitaxel in HER2- Breast Cancer Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Pembrolizumab Plus Paclitaxel in HER2- Breast Cancer Clinical Trial page

  1. Check
    2 days ago
    No Change Detected
  2. Check
    9 days ago
    No Change Detected
  3. Check
    16 days ago
    Change Detected
    Summary
    A new Revision: v3.4.2 tag appeared, and the prior government funding/operating status notice was removed. To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.4%
    Check dated 2026-02-11T14:11:43.000Z thumbnail image
  4. Check
    23 days ago
    Change Detected
    Summary
    A site-wide funding notice about government funding delays has been added, and the page shows a new revision banner (v3.4.1) replacing the previous v3.4.0.
    Difference
    0.4%
    Check dated 2026-02-04T10:29:52.000Z thumbnail image
  5. Check
    30 days ago
    Change Detected
    Summary
    The page shows a Show glossary option and minor text updates, including capitalization changes to 'Last Update Submitted that Met QC Criteria' and 'No FEAR Act Data', plus a new 'Revision: v3.4.0' banner. To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.2%
    Check dated 2026-01-28T06:25:50.000Z thumbnail image
  6. Check
    44 days ago
    Change Detected
    Summary
    Revision: v3.3.4 has been added and Revision: v3.3.3 has been removed from the Study Documents section. This is a minor metadata update that does not affect study content, results, or how users interact with the page. To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.1%
    Check dated 2026-01-14T02:11:41.000Z thumbnail image
  7. Check
    66 days ago
    Change Detected
    Summary
    The page now lists a specific Location (Charlotte, North Carolina) under Locations. The old North Carolina Locations entry and the HHS Vulnerability Disclosure link were removed, and the page revision updated from v3.3.2 to v3.3.3.
    Difference
    0.2%
    Check dated 2025-12-23T08:50:10.000Z thumbnail image
  8. Check
    88 days ago
    Change Detected
    Summary
    Footer revision updated from v3.3.1 to v3.3.2. To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.1%
    Check dated 2025-12-01T17:31:14.000Z thumbnail image

Stay in the know with updates to Pembrolizumab Plus Paclitaxel in HER2- Breast Cancer Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Pembrolizumab Plus Paclitaxel in HER2- Breast Cancer Clinical Trial page.